Canada markets open in 8 hours 30 minutes

Defence Therapeutics Inc. (DTCFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.9049-0.0574 (-5.97%)
At close: 11:22AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-06-30
2021-06-30
2020-06-30
Total Revenue
0
0
0
0
Operating Expenses
Research Development
4,325
3,760
1,159
433.451
Selling General and Administrative
2,643
3,560
1,701
239.731
Total Operating Expenses
6,990
7,320
2,859
673.182
Operating Income or Loss
-6,990
-7,320
-2,859
-673.182
Total Other Income/Expenses Net
-69.34
-23.867
-
-
Income Before Tax
-7,212
-7,344
-2,859
-673.182
Income from Continuing Operations
-7,212
-7,344
-2,859
-673.182
Net Income
-7,212
-7,344
-2,859
-673.182
Net Income available to common shareholders
-7,212
-7,344
-2,859
-673.182
Basic EPS
-0.19
-0.20
-0.11
-0.02
Diluted EPS
-0.19
-0.20
-0.11
-0.02
Basic Average Shares
37,989
36,077
26,596
34,799
Diluted Average Shares
37,989
36,077
26,596
34,799